Atul Mohindra, head of R&D at Lonza Integrated Biologics, spoke with PharmTech about some of the recent advancements in analytical techniques for biopharmaceutical development and manufacturing.
Atul Mohindra
Advertisement
Atul Mohindra is vice president of R&D for Lonza Integrated Biologics where he brings more than 20 years of experience in cell biology, bioprocessing, media development, and process scale up experience to translate scientific innovation into scalable manufacturing processes.
In this role, he leads a team focused on developing and implementing innovative bioprocessing and analytical solutions across the product lifecycle. One current focus for our team is integrating technologies such as advanced process analytical technologies, automation, and digital tools to improve process understanding, accelerate development timelines, and enable more robust and predictable biologics manufacturing.
Articles by Atul Mohindra
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Seventeen Peptide Guidance Revised: What Developers Need to Know
2
GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy
3
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
4
FDA's Manufacturing Registration Rule's Impact on Advanced Therapies: Part 1
5